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The functional complementation of two Escherichia coli strains defective in the succinylase pathway of
meso-diaminopimelate (meso-DAP) biosynthesis with a Bordetella pertussis gene library resulted in the isolation
of a putative dap operon containing three open reading frames (ORFs). In line with the successful comple-
mentation of the E. coli dapD and dapE mutants, the deduced amino acid sequences of two ORFs revealed
significant sequence similarities with the DapD and DapE proteins of E. coli and many other bacteria which
exhibit tetrahydrodipicolinate succinylase and N-succinyl-L,L-DAP desuccinylase activity, respectively. The first
ORF within the operon showed significant sequence similarities with transaminases and contains the char-
acteristic pyridoxal-5*-phosphate binding motif. Enzymatic studies revealed that this ORF encodes a protein
with N-succinyl-L,L-DAP aminotransferase activity converting N-succinyl-2-amino-6-ketopimelate, the product
of the succinylase DapD, to N-succinyl-L,L-DAP, the substrate of the desuccinylase DapE. Therefore, this gene
appears to encode the DapC protein of B. pertussis. Apart from the pyridoxal-5*-phosphate binding motif, the
DapC protein does not show further amino acid sequence similarities with the only other known enzyme with
N-succinyl-L,L-DAP aminotransferase activity, ArgD of E. coli.
D,L-Diaminopimelate (D,L-DAP) is the direct precursor of
L-lysine and moreover an important constituent of the cell wall
peptidoglycan of many bacteria (39). There are three alterna-
tive pathways in bacteria leading to the synthesis of D,L-DAP
(29): (i) the dehydrogenase variant in which the intermediate
tetrahydrodipicolinate (THDP) common to all three pathways
is converted in a single step to DAP, (ii) the succinylase variant
involving two succinylated intermediates, and (iii) the acetylase
variant using the acetyl residue instead of succinyl as the block-
ing group (Fig. 1).
In the succinylase pathway, THDP is converted by the suc-
cinyltransferase (DapD) to N-succinyl-2-amino-6-ketopime-
late, which is the substrate of the aminotransferase DapC. Its
product, N-succinyl-L,L-DAP, is converted by DapE, a desuc-
cinylase, to the common product of both the succinylase and
acetylase pathways, L,L-DAP (27). The acetylase and/or dehy-
drogenase pathways are found among members of the genus
Bacillus (38), while the succinylase pathway is present in Esch-
erichia coli (18). In Corynebacterium glutamicum, both the suc-
cinylase and dehydrogenase pathways can operate in D,L-DAP
and L-lysine biosynthesis (30). This high variability and flexi-
bility of DAP pathways might ensure the availability of a suf-
ficient amount of meso-DAP for cell wall synthesis under dif-
ferent environmental conditions (37). In addition to the vital
role of DAP in the cross-linking of the glycan backbones in the
bacterial cell wall and in providing lysine for protein biosyn-
thesis, DAP is a central constituent in the Bordetella pertussis
tracheal cytotoxin, which is an important virulence factor that
causes several pathological effects in epithelial cells (7, 21).
Since DAP is neither produced nor required by humans,
many efforts have been made to study DAP biosynthetic en-
zymes (8, 24, 28), and DAP analogs are evaluated for their
potential to inhibit bacterial growth. Furthermore, the use of
DAP auxotrophic mutants of Mycobacterium tuberculosis, My-
cobacterium bovis BCG, Salmonella subspecies, or Helicobacter
pylori as attenuated vaccine strains or for the maintenance of
cloning vectors expressing foreign antigens in such attenuated
strains has been proposed (9, 17, 23).
Although the biochemistry of the DAP-lysine pathway is
very well understood, the genes encoding enzymes involved in
this pathway have not been completely characterized. Indeed,
only three out of the four genes required for the succinyl
pathway of E. coli, dapD, dapE, and dapF, encoding THDP
succinylase, N-succinyl-L,L-DAP desuccinylase, and DAP epimer-
ase, respectively, were known (2). Surprisingly, despite the
availability of the entire genomic sequence of E. coli and other
bacteria, a gene encoding the N-succinyl-L,L-DAP aminotrans-
ferase had not been identified in any organism. Only recently,
ArgD of E. coli was shown to exhibit both N-acetylornithine
and DAP aminotransferase activity, which indicates its partic-
ipation not only in the arginine but also in the DAP-lysine
biosynthesis pathways (20). In the present paper we describe a
novel gene locus of B. pertussis containing the dapD and dapE
genes as well as a third gene that was characterized as dapC,
encoding a novel N-succinyl-L,L-DAP aminotransferase. The
identification of this gene will contribute to our understanding
of the DAP biosynthesis pathways and possibly to the devel-
opment of novel antimicrobials targeting these essential ana-
bolic pathways.
MATERIALS AND METHODS
Strains, plasmids, and growth conditions. Strains and plasmids used are listed
in Table 1. E. coli strains were grown in Luria-Bertani medium (Gibco), and B.
pertussis was grown on Bordet-Gengos (BG) agar plates supplemented with 15%
sheep blood (3), in Stainer-Scholte broth (33), or in Stainer-Scholte broth with
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Casamino Acids in place of defined amino acid solutions (13). When appropri-
ate, ampicillin (100 mg/ml), streptomycin (100 mg/ml), gentamicin (10 mg/ml),
nalidixic acid (20 mg/ml), DAP (40 mg/ml), or lysine (50 mg/ml) was added.
Strains were grown aerobically at 37°C with the exception of E. coli RDE51,
which was cultivated at 30°C. The preparation of competent cells, transforma-
tions, plasmid preparations, and DNA manipulations were performed according
to standard protocols (26).
Complementation of E. coli mutants auxotrophic for DAP biosynthesis. High-
molecular-weight chromosomal DNA of the Tohama I wild-type strain was
isolated as described previously (12) and digested with EcoRI. Fragments with an
average size of 1 to 8 kb were ligated into the EcoRI-cleaved and calf intestinal
alkaline phosphatase-dephosphorylated pBluescript SK vector and cloned in E.
coli DH5a (Stratagene, San Diego, Calif.). For complementation analyses, two
DAP auxotrophic E. coli strains, RDE51 and AT982, lacking functional dapE
and dapD loci, respectively, which are able to grow only in the presence of 50 mg
of diaminopimelic acid per ml (a mixture of the three DAP isomers; Sigma
Chemical Co., St. Louis, Mo.), were used. Competent cells of the RDE51 and
AT982 strains were transformed with the pBluescript SK gene library from B.
pertussis and selection was carried out on Luria-Bertani agar containing ampi-
cillin (50 mg/ml) but no diaminopimelic acid. Plasmid DNA was isolated from
colonies grown overnight or after 2 days of incubation.
Construction of a deletion in the dapC gene. The plasmid pSK-dapC was
digested with NcoI and religated, resulting in a 228-bp in-frame deletion within
the dapC gene (pSK-DdapC) (see Fig. 2). An EcoRI-BamHI fragment was
cloned into the vector pSS1129, resulting in the construct pSS-DdapC, which was
then transformed in the E. coli strain SM10 (31). Plasmid pSS-DdapC was then
conjugated into B. pertussis Tohama I, plating the bacteria on BG agar plates
containing DAP and lysine. Selection for allelic exchange was carried out as
described elsewhere (6, 34). The presence of the deletion in the dapC gene in the
respective mutants was verified by Southern blot analysis and by PCR with
specific oligonucleotides (26).
DNA sequence analysis. DNA fragments derived from B. pertussis and com-
plementing the E. coli dapD and dapE mutants were sequenced using the Ap-
plied Biosystems Prism sequencing kit from Perkin-Elmer and the automated
sequencer ABI Prism 310. Sequence data for both strands were obtained by
subcloning and primer walking. Analysis of the nucleotide sequences was per-
formed using the Genetics Computer Group program package (10). Protein
homology searches were conducted in the SwissProt database using the FASTA
and TFASTA programs and in the Prosite database using the MOTIFS program
and were further elaborated using the PILEUP program.
Determination of transaminase activity. E. coli was grown on minimal medium
consisting of (per liter) 7 g of KH2PO4, 3 g of K2HPO4, 1 g of (NH4)2SO4, 246
mg of MgSO4 z 7H2O, 1 mg of CaCl2 z 2H2O, 0.5 mg of FeSO4 z 7H2O, 0.5 mg
of MnSO4 z 4H2O, 0.5 mg of ZnSO4 z H2O, 0.1 mg of CuSO4 z 5H2O, 0.05 mg of
thiamine, and 5.5 g of glucose z H2O. Cells were harvested after overnight
incubation at 37°C, washed with 0.9% NaCl, resuspended in 20 mM Tris-HCl
(pH 8.0), and disrupted with a microtip-equipped sonifier. The homogenate was
centrifuged for 20 min at 20,000 3 g, and the resulting extract was applied to a
PD-10 column (Amersham-Pharmacia). Determination of the N-acyl-L,L-DAP
FIG. 1. The split pathway for the synthesis of DAP and lysine in prokaryotes.
On the left is shown the succinylase branch, and on the right is shown the
dehydrogenase branch. The acetylase variant in the middle is comparable to the
succinylase variant but uses acetyl groups instead of succinyl groups. The symbols
for genes are given below the enzymes.
TABLE 1. Bacterial strains and plasmids used in this study
Strain or plasmid Genotype or relevant characteristic(s) Reference or source
Strains
E. coli
DH5a F2 recA1 endA1 gyrA96 thi-1 hsdR17(rK
2 mK
1) sup44 relA1 l2 f80dlacZDM15(lacZYA-
argF)U169
Gibco BRL
DH5aMCR F2 mcrA D(mrr-hsdRMS-mcrBC) f80dlacZDM15 D(lacZYA-argF)U169 deoR recA1 endA1
supE44 l2 thi-1 gyrA96 relA1
14
RDE51 araD139 thi D(lac)U168 strA dapE::MuCts 25
AT982 rel-1 thi-1 dapD4 7
AT997 rel-1 thi-1 dapC15 7
SM10 RP4-2-Tc::Mu thi thr leu suIII Kan
r; mobilizing donor strain 31
B. pertussis
Tohama I (TI) Wild type Rino Rappuoli
TIDdapC Allelic exchange mutant of TI with a 228-bp deletion in dapC This study
Plasmids
pBluescript SK High-copy cloning vector Stratagene
pSS1129 Bordetella suicide vector 34
pSK50 5.0-kb EcoRI fragment from TI in pSK including the dap operon of B. pertussis (Fig. 2) This study
pSK-dapC 2.9-kb ApaI fragment from pSK50 containing dapC and truncated dapD (Fig. 2) This study
pSK-DdapC Derivative of pSK-dapC with a 228-bp NcoI deletion This study
pSS-DdapC EcoRI-BamHI fragment from pSK-DdapC joined to pSS1129 This study
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aminotransferase activity (EC 2.6.1.17) was based on the succinyl-DAP (or
acetyl-DAP-)-dependent formation of glutamate from a-ketoglutarate. The as-
say system consisted of 200 mM Tris-HCl (pH 8.0), 0.25 mM pyridoxal-59-
phosphate, 4 mM a-ketoglutarate, 8 mM acyl-2,6-DAP, 1 mM EDTA, and
gel-filtered extract. Assay mixtures were incubated at 37°C. Samples (30 ml) were
taken at different time intervals, and reactions were stopped by addition of 30 ml
of stop reagent (0.75 M HClO4 in 7 M ethanol), neutralized with 20 ml of
neutralizing solution (0.1 M K2CO3, 20 mM Tris-HCl [pH 8.0]), and used for
glutamate quantification. This was done by automated precolumn derivatization
with o-phthaldialdehyde, followed by separation by reversed phase chromatog-
raphy (LC ChemStation HP 1900) with fluorometric detection (15). Protein
concentration was determined after precipitation of the protein (1). All experi-
ments were carried out at least three times.
Nucleotide sequence accession number. The nucleotide sequence of the 5.0-kb
EcoRI fragment containing the dapCDE genes of B. pertussis has been deposited
in the EMBL data bank under accession number AJ009834.
RESULTS
Cloning and characterization of the dap locus of B. pertussis.
A partial gene bank from B. pertussis Tohama I DNA digested
with EcoRI was established in the high-copy-number vector
pBluescript SK and was used to identify six plasmids conferring
a stable DAP prototrophy to the E. coli dapE mutant RDE51.
All six plasmids contained a 5.0-kb EcoRI fragment (pSK50)
that was also able to complement the E. coli dapD mutant
AT982, which is blocked in the succinylase step of DAP bio-
synthesis (Fig. 1). The successful complementation of both E.
coli strains, RDE51 and AT982, indicated a close linkage of the
dapD and dapE genes in B. pertussis.
The complete nucleotide sequence of the 5.0-kb EcoRI frag-
ment of pSK50 was determined using a primer walking strat-
egy. The DNA fragment contains three open reading frames
(ORFs) consisting of 1,191, 819, and 1,137 bp, encoding puta-
tive proteins of 397, 273, and 379 amino acids (Fig. 2), respec-
tively. A tRNA gene coding for the rare tRNALeuW was found
immediately upstream of the start codon of ORF1. In all three
ORFs only one codon specific for this tRNA is present, located
in ORF1 at nucleotide position 58 to 60 (see Fig. 4). ORFs 1
and 2 are separated by 26 nucleotides. ORF2 and ORF3 over-
lap by one codon, indicating translational coupling of the two
genes, suggesting that the three ORFs are organized in an
operon.
Search for sequence similarities of the putative ORFs. The
5.0-kb EcoRI fragment derived from B. pertussis complements
auxotrophic E. coli mutants with defective dapD and dapE
genes on media lacking DAP. Indeed, the growth characteris-
tics of the complemented mutants are very similar to that of
the E. coli wild-type strain (data not shown). Consequently,
comparison of the amino acid sequences revealed high simi-
larities between the putative protein encoded by ORF2 and the
DapD proteins from E. coli (25), Haemophilus influenzae (11),
and Actinobacillus pleuropneumoniae (19) and between the
protein deduced from the DNA sequence of ORF3 and the
DapE proteins from E. coli (4), H. influenzae (11), and H. pylori
(36). Similarities shown in Fig. 3 range from 79 to 82% (DapD)
and from 58 to 77% (DapE). These data demonstrate that
ORF2 and ORF3 do indeed code for the Bordetella counter-
parts of the THDP succinylase DapD and the N-succinyl-L,L-
DAP desuccinylase DapE, respectively.
ORF1 encodes a hypothetical protein with an overall amino
acid similarity of about 40% to several putative proteins from
H. pylori (36), Bacillus subtilis (32), Synechocystis sp. (16) and
other bacteria (Fig. 4). The motif search revealed that the
amino acid sequences of ORF1 and the homologous proteins
contain a pyridoxal-59-phosphate attachment site (Fig. 4),
which is a characteristic feature of transaminases (35). Accord-
ingly, at least one of the proteins with significant sequence
similarities to B. pertussis ORF1, AspB from B. subtilis, was
shown to exhibit aminotransferase activity (32).
Characterization of ORF1 and elucidation of its function as
a transaminase involved in DAP biosynthesis. The sequence
analysis and the close linkage of ORF1 to the THDP succiny-
lase- and N-succinyl-L,L-DAP desuccinylase-encoding genes
dapD and dapE suggested that it might encode the N-succinyl-
L,L-DAP aminotransferase converting the product of the suc-
cinylase to the substrate of the desuccinylase. We therefore
FIG. 2. Schematic representation of the dapCDE gene locus of B. pertussis. The arrows below the ORFs indicate their transcriptional polarity. Below the dapCDE
operon the different subclones used in this study are indicated.
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functionally characterized the gene product of ORF1 by di-
rectly assaying for transaminase activity. For this purpose, the
E. coli strain DH5aMCR was transformed with pSK50 con-
taining the 5.0-kb EcoRI fragment with the entire operon con-
sisting of ORF1, dapD, and dapE, with plasmid pSK-dapC, a
derivative of pSK50 containing only ORF1 and a truncated
dapD, or, as controls, with plasmid pSK-DdapC or the vector
alone (Fig. 2). When the extracts of the two control strains
were incubated with succinyl-DAP and a-ketoglutarate, forma-
tion of L-glutamate was obtained only due to the chromosoma-
lly encoded transaminase activity of E. coli (Fig. 5A). However,
when the extract of E. coli pSK50 or pSK-dapC was used in the
enzyme assay, a significant increase in succinyl-DAP-depen-
dent L-glutamate accumulation was observed (Fig. 5A). Based
on the amount of protein present in the respective assay of
recombinant E. coli strains, the following specific activities (in
micromoles minute21 milligram of protein21) were deter-
mined by subtracting the basal activity and by calculation of the
amount of protein present in the assay: with pSK50, 0.014 6
0.006, and with pSK-dapC, 0.013 6 0.005. Therefore, ORF1
exhibits transaminase activity and was accordingly designated
dapC. In addition to succinyl-DAP, acetyl-DAP was also ap-
plied as a substrate for the transaminase, since the various
bacteria analyzed so far possess succinyl-DAP- or acetyl-DAP-
specific enzyme activities when assayed in crude extracts (30,
38). Using acetyl-DAP as an alternative substrate, a significant
activity with extracts of E. coli pSK50 and pSK-dapC was de-
tected (Fig. 5B), whereas extracts of E. coli pSK and pSK-
DdapC showed almost no transaminase activity. The specific
activity for extracts of E. coli pSK50 or pSK-dapC with acetyl-
DAP as the substrate was calculated (see above) to be
0.0047 6 0.001 mmol min21 mg of protein21. The low back-
ground activity is consistent with the inability of the E. coli
enzyme to use acetyl-DAP as a substrate when assayed in
extracts.
Characterization of a B. pertussis dapC mutant. To further
substantiate the participation of ORF1 in the DAP-lysine bio-
synthesis pathway, we tried to introduce by allelic exchange the
dapC allele containing the deletion of its pyridoxal phosphate
binding motif into the chromosome of B. pertussis. However,
despite the addition of DAP and lysine to the selection me-
dium, after several independent attempts we were able to iden-
tify only a single mutant out of several hundred clones
screened that carried the deletion within the dapC gene (data
not shown). The only obvious phenotype of this mutant was a
significantly reduced generation time compared with that of
the wild type (7.05 6 0.60 h versus 5.57 6 0.30 h). The addition
of DAP or lysine to the medium had no obvious effect and did
not influence the generation time of this mutant.
DISCUSSION
The investigation of a chromosomal locus of B. pertussis able
to complement E. coli dapD and dapE mutants led to the
identification of a new gene, dapC. Due to the close linkage of
these three genes they appear to constitute an operon with
dapC being the first gene in the order of transcription. The
dapD and dapE genes encode enzymes with THDP succinylase
and N-succinyl-L,L-DAP desuccinylase activity, respectively,
and their amino acid sequences show extensive similarities with
FIG. 3. Sequence homologies between the DapD and DapE proteins of several bacteria. Shown are multiple sequence alignments of DapD of A. pleuropneumoniae
(GenBank accession number P41396), H. influenzae (GenBank accession number P45284), and E. coli (GenBank accession number K02970) to the product of ORF2
(DapD B. pertussis) (A) and of DapE of E. coli (GenBank accession number X57403), H. influenzae (GenBank accession number P444514), and H. pylori (36) (HP0212)
(B) to the product of ORF3 (DapE B. pertussis). Amino acids identical or similar in at least three proteins are shaded. Groups of similar amino acids are as follows:
D, E, Q, and N; A, S, G, P, and T; F, Y, and W; K, H, and R; V, L, I, and M; and C.
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their E. coli counterparts (Fig. 3). The dapC gene codes for a
protein sharing significant sequence similarities with several
aminotransferases. The presence of the dapC gene within the
putative DAP operon prompted us to investigate its possible
involvement in DAP biosynthesis. In fact, a transaminase is
required to convert the product of DapD, N-succinyl-2-amino-
6-ketopimelate, to the substrate of DapE, N-succinyl-L,L-2,6-
DAP. Accordingly, transaminase activity could be detected in
crude lysates of an E. coli strain transformed with the B. per-
tussis dapC gene using N-succinyl-DAP as a substrate. Inter-
estingly, N-acetyl-DAP was also accepted as a substrate, al-
though with about half of the activity observed for N-succinyl-
DAP. We conclude that dapC encodes the transaminase
involved in DAP biosynthesis of B. pertussis and that its most
likely substrate in vivo is N-succinyl-L,L-DAP.
In early experiments with extracts of E. coli, Weinberger and
Gilvarg (38) demonstrated a quite strict requirement of the E.
coli N-succinyl-L,L-DAP aminotransferase, which accepted N-
succinyl-L,L-DAP but not N-succinyl-meso-DAP as a substrate.
More recently, similar experiments using the purified enzyme
contradicted these findings and showed that the purified E. coli
transaminase accepted compounds with rather large structural
alterations at the position of the succinyl group (8). These data
are in agreement with our results regarding the substrate spec-
ificity of the B. pertussis enzyme. In fact, many transaminases
are known to exhibit quite relaxed substrate specificities (30).
The apparently much less pronounced sequence conservation
among DapC homologs of different bacteria as compared to
the strong sequence conservation of DapD or DapE proteins
of different organisms (Fig. 3 and 4) could represent the struc-
tural counterpart of this characteristic feature.
In the literature confusion still exists regarding the gene
symbol-enzyme relationships of the dapC and dapD genes (22),
and in several database annotations dapD genes are still incor-
rectly reported to encode the N-succinyl-L,L-DAP aminotrans-
ferases instead of the THDP succinylases (2). Moreover, in
none of the bacterial genomes sequenced so far could a can-
didate gene encoding a DAP-specific aminotransferase be
identified (20). In this respect, it is worth mentioning that the
B. pertussis dapCDE locus was not able to functionally com-
plement the only available E. coli strain (AT997) (data not
shown) that was isolated as a dapC mutant (5) but later did not
prove to have a clear phenotype. In fact, it was impossible to
reconcile the originally reported map position of the mutation
and the genome sequence of E. coli.
A major breakthrough in our understanding of these puz-
zling findings was recently achieved in a study which shows that
in E. coli the argD-encoded N-acetylornithine aminotransfer-
ase also exhibits N-succinyl-L,L-DAP aminotransferase activity
and appears to be engaged in both pathways (20). This finding
is of particular importance because it may provide an expla-
nation for the unusual difficulties we experienced with the
FIG. 4. Sequence homologies between DapC and several putative amino-
transferases. Shown is a multiple sequence alignment of DapC from B. pertussis
and the product of three ORFs from H. pylori (36) (HP0624), B. subtilis (Gen-
Bank accession number P53001), and Synechocystis sp. (GenBank accession
number D64000). Amino acids identical or similar in at least three positions are
shaded. Groups of similar amino acids are as given in the legend to Fig. 3. The
arrow indicates the consensus sequence of the pyridoxal-59-phosphate binding
site common to several aminotransferases. The active site lysyl residue that binds
pyridoxal phosphate through Schiff base linkage is found within this consensus
sequence at position 256. The bar below the sequence marks 76 amino acids which
were deleted in pSK-DdapC. The only specific codon for the rare tRNALeuW
encoded by a gene immediately upstream of ORF1 is marked by an asterisk.
FIG. 5. Transaminase activity in crude extracts of E. coli strains harboring
plasmids containing different parts of the B. pertussis dapCDE locus, as quanti-
fied by L-glutamate accumulation, with either pSK50 ( n ) or pSK (F) and N-
succinyl-L,L-DAP as substrate (A) or with either pSK-dapC (n ) or pSK (F) and
N-acetyl-L,L-DAP as substrate (B). The protein amount in the respective assay
was 37 mg with pSK50 and 22 mg with pSK (Fig. 5A) and 114 mg with pSK50 and
44 mg with pSK (Fig. 5B), respectively.
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genetic inactivation of the dapC gene of B. pertussis. Assuming
that the dapC gene product is participating in additional bio-
synthetic pathways, its deletion may require suppressor muta-
tions in other aminotransferases, which generally show quite
low substrate specificities, to supply the lost function(s). In
fact, the only dapC mutant of B. pertussis that was obtained
exhibits a general growth defect which appears to be indepen-
dent of the presence of DAP or lysine in the culture medium.
The involvement of the B. pertussis DapC protein in additional
pathways will be the subject of future investigations.
It is interesting that, apart from the pyridoxal-59-phosphate
binding motif, the DapC protein of B. pertussis and ArgD of E.
coli do not show further amino acid sequence similarities, and
accordingly, BLAST searches with DapC in the E. coli genome
sequence or vice versa with ArgD in the B. pertussis genome
sequence resulted in the alignment with several other putative
aminotransferases with high significance values, but not with
each other (data not shown). The identification of ArgD of E.
coli and of DapC of B. pertussis as enzymes with N-succinyl-
L,L-DAP aminotransferase activities finally solves a long-last-
ing debate and closes an important gap in our knowledge about
this crucial biosynthetic pathway specific to eubacteria. More-
over, the involvement of proteins with entirely different pri-
mary structures in identical biosynthetic steps poses interesting
evolutionary questions and has important consequences for the
design of antimicrobial drugs directed against such enzymes.
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